Aldurazyme

Product manufactured by Genzyme Corporation

Application Nr Approved Date Route Status External Links
BLA125058 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Aldurazyme ® Is Indicated For Adult And Pediatric Patients With Hurler And Hurler-Scheie Forms Of Mucopolysaccharidosis I (Mps I) And For Patients With The Scheie Form Who Have Moderate To Severe Symptoms. Limitations Of Use: The Risks And Benefits Of Treating Mildly Affected Patients With The Scheie Form Have Not Been Established. Aldurazyme Has Not Been Evaluated For Effects On The Central Nervous System Manifestations Of The Disorder. Aldurazyme Is A Hydrolytic Lysosomal Glycosaminoglycan (Gag)-Specific Enzyme Indicated For Adult And Pediatric Patients With Hurler And Hurler-Scheie Forms Of Mucopolysaccharidosis I (Mps I) And For Patients With The Scheie Form Who Have Moderate To Severe Symptoms. ( 1 ) Limitations Of Use: The Risks And Benefits Of Treating Mildly Affected Patients With The Scheie Form Have Not Been Established. ( 1 ) Aldurazyme Has Not Been Evaluated For Effects On The Central Nervous System Manifestations Of The Disorder.( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Laronidase

Comments